Vendor, Cambridge, MA
Public Health Vaccines LLC
UEI SX5LJU3KWF93, CAGE 83L90
1 award and $60,426,909 obligated between February 29, 2024 and June 8, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $60,426,909 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $60,426,909 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50119C00022Definitive Contract, February 29, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Advanced Research and Development of Rvsv-Marv Vaccine.NAICS 541714, PSC AN13 | $60,426,909 |
- Places of performance
- Massachusetts
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 8 across 1 awards